Johnson & Johnson Acquires Alios BioPharma for $1,750,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=567723f1-ad17-4e48-b381-0f1efa4d7645 - Date
10/1/2014 - Company Name
Alios BioPharma - Mailing Address
260 East Grand Ave 2nd Floor South San Francisco, CA 94080 USA - Company Description
Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). - Website
http://www.aliosbiopharma.com - Transaction Type
M&A - Transaction Amount
$1,750,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The acquisition will be paid for with all cash.
